NCT03759366 · Interventional trial
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)
Overall registry status Completed
Phase 3
Conditions Myasthenia Gravis, Myasthenia Gravis, Generalized, Myasthenia Gravis, Juvenile Form
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory